Dyadic Attends Investor Events in December
November 30, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic Attends Investor Events in December
USDA Awards $25 Million Loan Guarantee to Ameris Bank for Liberation Labs Biomanufacturing Facility in Indiana
November 30, 2023 08:00 ET
|
Liberation Labs
USDA Awards $25 Million Loan Guarantee to Ameris Bank for Liberation Labs' Biomanufacturing Facility in Indiana
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 08, 2023 16:00 ET
|
Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
Dyadic to Present at Industry Events in November
October 30, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic to Present at Industry Events in November
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
October 25, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Global Human Nutrition Alternative Protein Ingredients Market Analysis Report 2023: B2B Market Dynamics of Plant Protein, Microbial Protein, and Insect Protein Ingredients
October 03, 2023 09:33 ET
|
Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Alternative Protein Ingredients for Human Nutrition" report has been added to ResearchAndMarkets.com's offering. This...
Dyadic to Present at Industry and Investor Events in October
September 29, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic to Present at Industry and Investor Events in October
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using Dapibus™
September 19, 2023 08:00 ET
|
Dyadic International, Inc.
Dyadic to receive upfront payment of $0.6 million for product development and licensing its Dapibus™ platform, in addition to potential success fees, milestones, and royalties. JUPITER, Fla., Sept. ...
Dyadic to Present at BioProcess International
September 12, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...